The NUVB Tug-of-War: 2023’s Market Gains and Losses Analyzed

DOYU

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a loss of -34.78%.However, over the last six months, we can see a stronger performance of -30.85%. Over the last 30 days, the price of NUVB has leaped by -13.72%. And in the last five days, it has fallen by -3.94%.

Nuvation Bio Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $3.97 on 07/31/24 and the lowest value was $1.54 on 04/07/25.

52-week price history of NUVB Stock

Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Nuvation Bio Inc’s current trading price is -50.88% away from its 52-week high, while its distance from the 52-week low is 26.62%. The stock’s price range during this period has varied between$1.54 and $3.97. The Nuvation Bio Inc’s shares, which operate in the Healthcare, saw a trading volume of around 8.34 million for the day, a figure considerably higher than their average daily volume of 5.28 million over last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

Nuvation Bio Inc (NUVB) has experienced a quarterly rise of 7.14% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 663.52M and boasts a workforce of 220 employees.

Combining Moving Average and Trading Volume Data for Better Market Insight

NUVB’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look

The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for NUVB stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.01.

Most Popular

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.